MCK MediSo: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MCK MediSo
Largest movements
- Current investments +€200,000
new in 2025: €200,000
- Financial fixed assets +€188,721
up €188,721 (+70.8%), from €266,504 to €455,224
- Receivables after one year -€81,764
down €81,764 (-17.5%), from €467,608 to €385,844
- Profit (loss) carried forward +€274,869
up €274,869 (+150%), from €183,160 to €458,029
- Gross operating margin +€276,826
up €276,826 (+502%), from €55,156 to €331,981
- Purchases and services -€218,526
down €218,526 (-61.5%), from €355,159 to €136,633
- Turnover +€25,624
up €25,624 (+42.9%), from €59,732 to €85,356
- Other operating charges +€22,855
up €22,855 (+172%), from €13,312 to €36,167
- Financial charges +€13,524
up €13,524 (+3,588%), from €377 to €13,901
of which Non-recurring financial charges: +€10,280
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €2,076,541 | €2,377,389 | +€300,848 | +14.5% |
| Fixed assets | 21/28 | €460,491 | €655,548 | +€195,056 | +42.4% |
| Tangible fixed assets | 22/27 | €193,988 | €200,323 | +€6,335 | +3.3% |
| Land and buildings | 22 | €179,104 | €200,043 | +€20,939 | +11.7% |
| Plant, machinery and equipment | 23 | €300 | €280 | -€20 | -6.7% |
| Other tangible fixed assets | 26 | €14,583 | - | -€14,583 | |
| Financial fixed assets | 28 | €266,504 | €455,224 | +€188,721 | +70.8% |
| Current assets | 29/58 | €1,616,050 | €1,721,842 | +€105,792 | +6.5% |
| Amounts receivable after more than one year | 29 | €467,608 | €385,844 | -€81,764 | -17.5% |
| Other amounts receivable | 291 | €467,608 | €385,844 | -€81,764 | -17.5% |
| Stocks and contracts in progress | 3 | €0 | - | = | |
| Stocks | 30/36 | €0 | - | = | |
| Amounts receivable within one year | 40/41 | €86,176 | €96,412 | +€10,236 | +11.9% |
| Trade receivables | 40 | €3,901 | €12,014 | +€8,112 | +208% |
| Other amounts receivable | 41 | €82,275 | €84,398 | +€2,124 | +2.6% |
| Current investments | 50/53 | - | €200,000 | +€200,000 | |
| Cash at bank and in hand | 54/58 | €1,051,450 | €1,035,178 | -€16,272 | -1.5% |
| Deferred charges and accrued income | 490/1 | €10,815 | €4,407 | -€6,408 | -59.2% |
| Total equity and liabilities | 10/49 | €2,076,541 | €2,377,389 | +€300,848 | +14.5% |
| Equity | 10/15 | €2,054,990 | €2,352,625 | +€297,635 | +14.5% |
| Contributions | 10/11 | €758,017 | €780,783 | +€22,766 | +3.0% |
| Capital | 10 | €758,017 | €780,783 | +€22,766 | +3.0% |
| Revaluation surpluses | 12 | €13,872 | €13,872 | = | 0.0% |
| Reserves | 13 | €1,099,941 | €1,099,941 | = | 0.0% |
| Profit (loss) carried forward | 14 | €183,160 | €458,029 | +€274,869 | +150% |
| Amounts payable | 17/49 | €21,551 | €24,764 | +€3,213 | +14.9% |
| Amounts payable within one year | 42/48 | €18,538 | €23,970 | +€5,433 | +29.3% |
| Trade debts | 44 | €11,011 | €19,467 | +€8,457 | +76.8% |
| Suppliers | 440/4 | €11,011 | €19,467 | +€8,457 | +76.8% |
| Taxes, remuneration and social security | 45 | €27 | €1,212 | +€1,185 | +4,395% |
| Taxes | 450/3 | €27 | €1,212 | +€1,185 | +4,395% |
| Accrued charges and deferred income | 492/3 | €3,013 | €794 | -€2,219 | -73.7% |
| Turnover | 70 | €59,732 | €85,356 | +€25,624 | +42.9% |
| Membership fees, donations, legacies and grants | 73 | €341,566 | €345,866 | +€4,300 | +1.3% |
| Non-recurring operating income | 76A | - | €2,312 | +€2,312 | |
| Goods, raw materials, services and sundry goods | 60/61 | €355,159 | €136,633 | -€218,526 | -61.5% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €19,743 | €23,972 | +€4,229 | +21.4% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | €8,005 | - | -€8,005 | |
| Other operating charges | 640/8 | €13,312 | €36,167 | +€22,855 | +172% |
| Gross operating margin | 9900 | €55,156 | €331,981 | +€276,826 | +502% |
| Operating profit (loss) | 9901 | €14,096 | €271,843 | +€257,747 | +1,829% |
| Financial income | 75/76B | €22,400 | €16,927 | -€5,473 | -24.4% |
| Recurring financial income | 75 | €22,400 | €16,927 | -€5,473 | -24.4% |
| Financial charges | 65/66B | €377 | €13,901 | +€13,524 | +3,588% |
| Recurring financial charges | 65 | €377 | €3,621 | +€3,244 | +861% |
| Non-recurring financial charges | 66B | - | €10,280 | +€10,280 | |
| Profit (loss) for the period before taxes | 9903 | €36,119 | €274,869 | +€238,750 | +661% |
| Profit (loss) for the period | 9904 | €36,119 | €274,869 | +€238,750 | +661% |
| Profit (loss) for the period to be appropriated | 9905 | €36,119 | €274,869 | +€238,750 | +661% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 25 October 2026 via checked.be.